Uninephrectomy and sodium‐glucose cotransporter 2 inhibitor administration delay the onset of hyperglycemia
Physiological Reports · 2024
DOI: 10.14814/phy2.70121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2024. Verfasst von Yuri Sakai Ishizaki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Nephrectomy, Glucosides, Hyperglycemia. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The kidneys are essential for glucose homeostasis, as they perform gluconeogenesis, utilize glucose, and reabsorb glucose. Reabsorption is performed by SGLT2, which is responsible for about 90%. However, little is known about how renal glucose handling is altered in patients with chronic kidney disease (CKD). SGLT2 inhibitors have demonstrated efficacy in suppressing CKD progression in clinical trials, but their mechanisms are not fully understood. Therefore, this study aimed to evaluate how each uninephrectomy (UNx) and SGLT2 inhibitor affects blood glucose concentrations and SGLTs dynamics in rats with type 2 diabetes mellitus. Male rats were divided into four treatment groups: sham + placebo, sham + dapagliflozin, UNx + placebo, and UNx + dapagliflozin. There were few group differences in food intake or body weight, but blood glucose concentrations continued to rise in the sham + placebo, whereas this rise was delayed for several weeks in the UNx + placebo, and largely suppressed by dapagliflozin. SGLT2 mRNA expression was significantly lower in the UNx group, but SGLT1 mRNA expression did not significantly differ. Dapagliflozin did not alter SGLT1 or SGLT2 mRNA expression. In animal models of diabetes, renal glucose reabsorption appears likely to be a major contributor to the development of hyperglycemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
ORCID-Profile: Yuri Sakai Ishizaki, Masao Kikuchi, Shouichi Fujimoto
Zitieren
APA
Ishizaki, Y. S., Kikuchi, M., Kaikita, K., & Fujimoto, S. (2024). Uninephrectomy and sodium‐glucose cotransporter 2 inhibitor administration delay the onset of hyperglycemia. Physiological Reports. https://doi.org/10.14814/phy2.70121
Vancouver
Ishizaki YS, Kikuchi M, Kaikita K, Fujimoto S. Uninephrectomy and sodium‐glucose cotransporter 2 inhibitor administration delay the onset of hyperglycemia. Physiological Reports. 2024. doi:10.14814/phy2.70121
BibTeX
@article{Ishizaki2024,
author = {Ishizaki, Yuri Sakai and Kikuchi, Masao and Kaikita, Koichi and Fujimoto, Shouichi},
title = {Uninephrectomy and sodium‐glucose cotransporter 2 inhibitor administration delay the onset of hyperglycemia},
journal = {Physiological Reports},
year = {2024},
doi = {10.14814/phy2.70121}
}
EUVIMED